InsidersTradesSigma
基于 5 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the detailed record of transactions filed by Khalid Nabilsi. Officer active across 1 company, notably Hikma Pharmaceuticals PLC. In total, 8 filings have been recorded. Regulator: RNS (LSE). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Khalid Nabilsi is a declarant with 8 filings in total. In the 8 sampled recent filings, all related to Hikma Pharmaceuticals PLC, the date range runs from 2024-03-13 to 2026-06-05, and the modal transaction nature is Purchase. His listed role at Hikma Pharmaceuticals PLC is Deputy CEO, North America and Europe.